Pemphigus Terminated Phase 3 Trials for Prednisone (DB00635)

IndicationStatusPhase
DBCOND0001806 (Pemphigus)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02613910Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus VulgarisTreatment